(Q33789991)

29 July 2017

title

Tolerability of alendronate. Comparison group taking placebo should have been included (English)

1 reference

29 July 2017

0 references

Kirby M

1

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 May 1998

1 reference

29 July 2017

1 reference

29 July 2017

volume

316

1 reference

29 July 2017

issue

7141

1 reference

29 July 2017

page(s)

1389-1390

1 reference

Incidence of gastrointestinal side effects due to alendronate is high in clinical practice

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1113090

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1113090

Esophagitis associated with the use of alendronate

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1113090

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1113090

Prescription-event monitoring (PEM) in 1996-a method of non-interventional observational cohort pharmacovigilance

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9564011

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BMJ.316.7141.1389A

1 reference

29 July 2017

1 reference

29 July 2017

1 reference